Health ❯ Healthcare

Consumer Safety

Product Recalls Adverse Effects Product Testing Product Regulation Health Risks Product Safety Product Quality Counterfeit Drugs Adverse Reactions Regulatory Actions

3.1 Million Bottles of Store-Brand Eye Drops Recalled for Sterility Concerns

The FDA labeled the ongoing action Class II to signal possible temporary harms.

Stories older than 24h

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

ANMAT Bans Unregistered Hair Treatments and Dental Suture Nationwide Over Safety Risks

Online Marketplaces Remove Melatonin Listings in UK After Which? Flags Illegal Sales

UKHSA Reissues Warning on Alcohol-Free Wipes Linked to Fatal Bacterial Outbreak

Honey Energy Supplement Recalled After FDA Finds Undeclared ED Drug

Brazil Investigates Suspected Infant Meningitis After Use of Recalled Nestlé Formula

FDA Orders Online Supplements Pulled Over Hidden Drugs and Allergens

Anvisa Orders Lot-Specific Recalls Over Packaging Mix-Ups, Seizes Falsified Drug Batches

MediNatura Recalls All ReBoost and ClearLife Nasal Sprays Over Contamination Risk

Walgreens Recalls Saline Nasal Spray After FDA Flags Bacterial Contamination

Australia Tightens Access to High‑Dose Vitamin B6 With New Pharmacist and Prescription Rules

Bondi Sands Recalls Five Batches of Zinc Mineral SPF 50+ Lotions Over Separation Risk

Peru Issues Consumer Alert as Perufarma Recalls Metformin Lot Over Foreign Particle

FDA Lists Class II Recall of 141,984 Bottles of Generic Atorvastatin

Cofepris Flags Falsified Humalog Mix 25 Insulin in Mexico

ANMAT Reasserts Nationwide Ban on Colgate Total Clean Mint Toothpaste

DermaRite Expands Recall to 30+ Personal-Care Products Over Bacterial Risk

FDA Details Lots as DermaRite Recall of Contaminated Soaps Continues

FDA Warns Viral Mousse Sunscreens for Unapproved Form and Misleading Packaging